Abstract: The invention relates to a tablet or capsule containing a plant extract, to assist in the treatment or prevention of disorders or diseases. The tablet or capsule includes bioconverted products provided by fermenting Withania Somnifera extract, Emblica officinalis extract, and Bacopa monnieri extract.
Type:
Grant
Filed:
May 21, 2018
Date of Patent:
September 28, 2021
Assignees:
Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
Abstract: Compounds for treating neurodegenerative disorders The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
Type:
Application
Filed:
December 11, 2017
Publication date:
March 18, 2021
Applicants:
ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Inventors:
Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.
Type:
Grant
Filed:
March 23, 2015
Date of Patent:
March 24, 2020
Assignee:
Ethnodyne and Centre National de la Recherche Scientifique (CNRS)
Abstract: The invention relates to a composition containing a Withania somnifera extract, obtained by fermentation by incubating the Withania somnifera extract with a filamentous fungus of the Beauveria genus. The composition can be used to treat or prevent ?-synucleinopathies in a subject.
Type:
Grant
Filed:
April 13, 2015
Date of Patent:
March 24, 2020
Assignees:
Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
Abstract: The invention relates to a tablet or capsule containing a plant extract, to assist in the treatment or prevention of disorders or diseases. The tablet or capsule includes bioconverted products provided by fermenting Withania Somnifera extract, Emblica officinalis extract, and Bacopa monnieri extract.
Type:
Application
Filed:
May 21, 2018
Publication date:
October 11, 2018
Applicants:
Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
Abstract: The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation.
Type:
Grant
Filed:
December 17, 2015
Date of Patent:
June 19, 2018
Assignees:
Ethnodyne, Centre National De La Recherche Scientifique (CNRS)
Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to prevent, treat of delay the progression of ?-synuclemopathies, including Parkinson disease.
Type:
Application
Filed:
April 13, 2015
Publication date:
April 26, 2018
Applicants:
Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.
Type:
Application
Filed:
March 23, 2015
Publication date:
February 15, 2018
Applicants:
Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
Abstract: The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation.
Type:
Application
Filed:
December 17, 2015
Publication date:
April 14, 2016
Applicants:
Ethnodyne, Centre National de la Recherche Scientifique (CNRS)